Writing a computer program made him a 1974 Westinghouse finalist. Now he practices psychiatry, using data to drive diagnoses--including that of an accused September 11, 2001, attack planner
A 2000 Intel Science Talent Search finalist's interest in science was sparked on her family's cattle ranch. Now she's studying for a PhD in biochemistry while managing bipolar disorder
A 1985 Westinghouse finalist studied climate change, and now teaches high school physics
A 1978 Westinghouse finalist studied physics, and now administers research at his home state's university
A Westinghouse finalist's childhood fascination with fossils turns into a career in paleontology
A 1984 Westinghouse finalist went from studying materials science to watching how others learn about matter
A 1989 Westinghouse finalist studied how elite players choose moves, now he advises companies on how to think about the price of power
A 1973 Westinghouse finalist built a moon launcher, but today he operates closer to the ground as an eye surgeon--and he flies his own plane
A 1967 Westinghouse finalist's project focused on ecology and crayfish, but his career aspirations led him to treat HIV/AIDS
A 1965 Westinghouse finalist used geometry to figure out how metals act at a molecular level, and now studies clusters of galaxies
WASHINGTON, D.C.—It’s no secret that many of America’s bridges are in sad shape. One of the reasons is the corrosion of the steel rebar used to strengthen concrete structures.
WASHINGTON, D.C. (March 10, 2009)—Stem cells have long been touted as potential cures or treatments for a variety of ailments from paralysis to Parkinson's disease.
WASHINGTON, D.C.—The excitement is building to a crescendo here as 40 top high school scientists wait for tonight's gala finale of Intel's Science Talent Search.
WASHINGTON, D.C.—When gas prices were sky high, lots of people talked about ethanol as a fuel of the future. In particular, many investors placed their hopes in cellulosic ethanol.
A 1986 Westinghouse finalist works to come up with better treatments for devastating childhood cancers
WASHINGTON, D.C.—People like sucralose—the artificial sweetener marketed as Splenda—because the human body can’t break it down and use it.